Pharmaceutical Commerce - August 2022 Issue (PDF)

Mitigating Drug Shortages

The latest news for pharma industry insiders.

April 12th 2024

From Toggling Tediously Between Systems to Achieving Whole-Person Care

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Image credit: Coloures-Pic | stock.adobe.com

April 22nd 2024

A Further Examination of Pharmacy Benefit Managers

The rationale behind transforming case management in healthcare.

March 29th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

Pharma Pulse 4/23/24: Meta Places Smart Assistants Across Its Apps, Burden of Pneumococcal Disease Consistent Across Age Groups & more

The latest news for pharma industry insiders.

Related Content

April 23rd 2024

Mitigating Drug Shortages

The latest news for pharma industry insiders.

April 12th 2024

From Toggling Tediously Between Systems to Achieving Whole-Person Care

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

April 22nd 2024

A Further Examination of Pharmacy Benefit Managers

The rationale behind transforming case management in healthcare.

March 29th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.